Experience in the Use of Recombinant Interleukin-2 in the Treatment of Children with Encephalitis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-11-17

AUTHORS

N. V. Skripchenko, G. P. Ivanova, G. F. Zheleznikova, V. N. Komantsev, A. V. Surovtseva

ABSTRACT

Study aim. The efficacy of Russian-produced recombinant interleukin-2 (IL-2) in the complex treatment of encephalitis was studied in children. Materials and methods. A total of 40 patients aged from six months to 17 years were treated. Drug was given at a dose of 0.5 mg/day by i.v. infusion for three days in acute cases and for five days in chronic cases. The reference group consisted of 35 patients with encephalitis, treated without study drug. Results. Use of recombinant IL-2 decreased the duration of developing symptoms by 5.4 ± 1.3 days, decreased neurological deficit on the EDSS on discharge from hospital by 1.6 ± 0.2 points, and decreased the frequency of acute exacerbations from 22.9% to 5% and the frequency of developing multiple sclerosis over three years from 17.1% to 2.5% (p ≤ 0.05). Efficacy correlated with positive changes in immunological parameters 3–4 weeks after treatment ended. Studies of multimodal evoked potentials in the brain during use of this drug showed that it had positive influences on the central afferent conduction time. There was a reduction in the proportion of patients with focal changes on follow-up MRI scans. Conclusions. Recombinant IL-2 is recommended for the treatment of children with encephalitis. More... »

PAGES

1095-1100

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11055-015-0191-8

DOI

http://dx.doi.org/10.1007/s11055-015-0191-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023353232


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia", 
          "id": "http://www.grid.ac/institutes/grid.445931.e", 
          "name": [
            "Research Institute of Childhood Infections, St. Petersburg, Russia", 
            "Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skripchenko", 
        "givenName": "N. V.", 
        "id": "sg:person.0635541170.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635541170.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia", 
          "id": "http://www.grid.ac/institutes/grid.445931.e", 
          "name": [
            "Research Institute of Childhood Infections, St. Petersburg, Russia", 
            "Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ivanova", 
        "givenName": "G. P.", 
        "id": "sg:person.0703654370.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703654370.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Childhood Infections, St. Petersburg, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Research Institute of Childhood Infections, St. Petersburg, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zheleznikova", 
        "givenName": "G. F.", 
        "id": "sg:person.0675000207.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675000207.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Childhood Infections, St. Petersburg, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Research Institute of Childhood Infections, St. Petersburg, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komantsev", 
        "givenName": "V. N.", 
        "id": "sg:person.01023414542.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023414542.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Childhood Infections, St. Petersburg, Russia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Research Institute of Childhood Infections, St. Petersburg, Russia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Surovtseva", 
        "givenName": "A. V.", 
        "id": "sg:person.0751767570.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751767570.37"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2015-11-17", 
    "datePublishedReg": "2015-11-17", 
    "description": "Study aim. The efficacy of Russian-produced recombinant interleukin-2 (IL-2) in the complex treatment of encephalitis was studied in children. Materials and methods. A total of 40 patients aged from six months to 17 years were treated. Drug was given at a dose of 0.5 mg/day by i.v. infusion for three days in acute cases and for five days in chronic cases. The reference group consisted of 35 patients with encephalitis, treated without study drug. Results. Use of recombinant IL-2 decreased the duration of developing symptoms by 5.4 \u00b1 1.3 days, decreased neurological deficit on the EDSS on discharge from hospital by 1.6 \u00b1 0.2 points, and decreased the frequency of acute exacerbations from 22.9% to 5% and the frequency of developing multiple sclerosis over three years from 17.1% to 2.5% (p \u2264 0.05). Efficacy correlated with positive changes in immunological parameters 3\u20134 weeks after treatment ended. Studies of multimodal evoked potentials in the brain during use of this drug showed that it had positive influences on the central afferent conduction time. There was a reduction in the proportion of patients with focal changes on follow-up MRI scans. Conclusions. Recombinant IL-2 is recommended for the treatment of children with encephalitis.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11055-015-0191-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015474", 
        "issn": [
          "0097-0549", 
          "1573-899X"
        ], 
        "name": "Neuroscience and Behavioral Physiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "keywords": [
      "recombinant interleukin-2", 
      "treatment of children", 
      "afferent conduction time", 
      "proportion of patients", 
      "acute exacerbation", 
      "study drug", 
      "neurological deficits", 
      "multiple sclerosis", 
      "chronic cases", 
      "acute cases", 
      "conduction time", 
      "MRI scans", 
      "interleukin-2", 
      "encephalitis", 
      "focal changes", 
      "patients", 
      "reference group", 
      "complex treatment", 
      "treatment", 
      "drugs", 
      "children", 
      "days", 
      "Studies of multimodal", 
      "efficacy", 
      "parameters 3", 
      "positive changes", 
      "EDSS", 
      "exacerbation", 
      "sclerosis", 
      "infusion", 
      "years", 
      "symptoms", 
      "hospital", 
      "follow", 
      "dose", 
      "weeks", 
      "months", 
      "brain", 
      "scans", 
      "total", 
      "cases", 
      "deficits", 
      "duration", 
      "use", 
      "group", 
      "changes", 
      "proportion", 
      "frequency", 
      "discharge", 
      "study", 
      "reduction", 
      "experience", 
      "multimodal", 
      "positive influence", 
      "time", 
      "potential", 
      "influence", 
      "method", 
      "point", 
      "materials", 
      "Russian", 
      "efficacy of Russian", 
      "immunological parameters 3", 
      "central afferent conduction time"
    ], 
    "name": "Experience in the Use of Recombinant Interleukin-2 in the Treatment of Children with Encephalitis", 
    "pagination": "1095-1100", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023353232"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11055-015-0191-8"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11055-015-0191-8", 
      "https://app.dimensions.ai/details/publication/pub.1023353232"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_676.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11055-015-0191-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11055-015-0191-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11055-015-0191-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11055-015-0191-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11055-015-0191-8'


 

This table displays all metadata directly associated to this object as RDF triples.

154 TRIPLES      21 PREDICATES      89 URIs      81 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11055-015-0191-8 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N30b2dc7193c944a89dbd5fcbecb53703
4 schema:datePublished 2015-11-17
5 schema:datePublishedReg 2015-11-17
6 schema:description Study aim. The efficacy of Russian-produced recombinant interleukin-2 (IL-2) in the complex treatment of encephalitis was studied in children. Materials and methods. A total of 40 patients aged from six months to 17 years were treated. Drug was given at a dose of 0.5 mg/day by i.v. infusion for three days in acute cases and for five days in chronic cases. The reference group consisted of 35 patients with encephalitis, treated without study drug. Results. Use of recombinant IL-2 decreased the duration of developing symptoms by 5.4 ± 1.3 days, decreased neurological deficit on the EDSS on discharge from hospital by 1.6 ± 0.2 points, and decreased the frequency of acute exacerbations from 22.9% to 5% and the frequency of developing multiple sclerosis over three years from 17.1% to 2.5% (p ≤ 0.05). Efficacy correlated with positive changes in immunological parameters 3–4 weeks after treatment ended. Studies of multimodal evoked potentials in the brain during use of this drug showed that it had positive influences on the central afferent conduction time. There was a reduction in the proportion of patients with focal changes on follow-up MRI scans. Conclusions. Recombinant IL-2 is recommended for the treatment of children with encephalitis.
7 schema:genre article
8 schema:inLanguage en
9 schema:isAccessibleForFree false
10 schema:isPartOf Na9ae40f172c140658f93fe4fdb3a1fa5
11 Nf479c574a2d04bedbd7dd671b28be111
12 sg:journal.1015474
13 schema:keywords EDSS
14 MRI scans
15 Russian
16 Studies of multimodal
17 acute cases
18 acute exacerbation
19 afferent conduction time
20 brain
21 cases
22 central afferent conduction time
23 changes
24 children
25 chronic cases
26 complex treatment
27 conduction time
28 days
29 deficits
30 discharge
31 dose
32 drugs
33 duration
34 efficacy
35 efficacy of Russian
36 encephalitis
37 exacerbation
38 experience
39 focal changes
40 follow
41 frequency
42 group
43 hospital
44 immunological parameters 3
45 influence
46 infusion
47 interleukin-2
48 materials
49 method
50 months
51 multimodal
52 multiple sclerosis
53 neurological deficits
54 parameters 3
55 patients
56 point
57 positive changes
58 positive influence
59 potential
60 proportion
61 proportion of patients
62 recombinant interleukin-2
63 reduction
64 reference group
65 scans
66 sclerosis
67 study
68 study drug
69 symptoms
70 time
71 total
72 treatment
73 treatment of children
74 use
75 weeks
76 years
77 schema:name Experience in the Use of Recombinant Interleukin-2 in the Treatment of Children with Encephalitis
78 schema:pagination 1095-1100
79 schema:productId N4d95d8870dae42b88c920ac1a440c027
80 N956bb956f1b14b94bf2ec07ee6eb3a03
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023353232
82 https://doi.org/10.1007/s11055-015-0191-8
83 schema:sdDatePublished 2021-12-01T19:34
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Nfdd26274c19640448c761c6dcb2361ae
86 schema:url https://doi.org/10.1007/s11055-015-0191-8
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N30b2dc7193c944a89dbd5fcbecb53703 rdf:first sg:person.0635541170.58
91 rdf:rest N4f376d5b549349568ff10aaf78b79a10
92 N3d29d2fc64d040e7a3815d729fe1d479 rdf:first sg:person.0751767570.37
93 rdf:rest rdf:nil
94 N4d95d8870dae42b88c920ac1a440c027 schema:name doi
95 schema:value 10.1007/s11055-015-0191-8
96 rdf:type schema:PropertyValue
97 N4f376d5b549349568ff10aaf78b79a10 rdf:first sg:person.0703654370.41
98 rdf:rest Ndfd40a29618b4709aec0807c7072952b
99 N956bb956f1b14b94bf2ec07ee6eb3a03 schema:name dimensions_id
100 schema:value pub.1023353232
101 rdf:type schema:PropertyValue
102 Na015e9afd2164d35a86ef4a5b99be7f1 rdf:first sg:person.01023414542.24
103 rdf:rest N3d29d2fc64d040e7a3815d729fe1d479
104 Na9ae40f172c140658f93fe4fdb3a1fa5 schema:volumeNumber 45
105 rdf:type schema:PublicationVolume
106 Ndfd40a29618b4709aec0807c7072952b rdf:first sg:person.0675000207.31
107 rdf:rest Na015e9afd2164d35a86ef4a5b99be7f1
108 Nf479c574a2d04bedbd7dd671b28be111 schema:issueNumber 9
109 rdf:type schema:PublicationIssue
110 Nfdd26274c19640448c761c6dcb2361ae schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
116 schema:name Clinical Sciences
117 rdf:type schema:DefinedTerm
118 sg:journal.1015474 schema:issn 0097-0549
119 1573-899X
120 schema:name Neuroscience and Behavioral Physiology
121 schema:publisher Springer Nature
122 rdf:type schema:Periodical
123 sg:person.01023414542.24 schema:affiliation grid-institutes:None
124 schema:familyName Komantsev
125 schema:givenName V. N.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023414542.24
127 rdf:type schema:Person
128 sg:person.0635541170.58 schema:affiliation grid-institutes:grid.445931.e
129 schema:familyName Skripchenko
130 schema:givenName N. V.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635541170.58
132 rdf:type schema:Person
133 sg:person.0675000207.31 schema:affiliation grid-institutes:None
134 schema:familyName Zheleznikova
135 schema:givenName G. F.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675000207.31
137 rdf:type schema:Person
138 sg:person.0703654370.41 schema:affiliation grid-institutes:grid.445931.e
139 schema:familyName Ivanova
140 schema:givenName G. P.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703654370.41
142 rdf:type schema:Person
143 sg:person.0751767570.37 schema:affiliation grid-institutes:None
144 schema:familyName Surovtseva
145 schema:givenName A. V.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751767570.37
147 rdf:type schema:Person
148 grid-institutes:None schema:alternateName Research Institute of Childhood Infections, St. Petersburg, Russia
149 schema:name Research Institute of Childhood Infections, St. Petersburg, Russia
150 rdf:type schema:Organization
151 grid-institutes:grid.445931.e schema:alternateName Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia
152 schema:name Department of Infectious Diseases in Children, Faculty of Postgraduate and Further Professional Education, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia
153 Research Institute of Childhood Infections, St. Petersburg, Russia
154 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...